Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001871747 | SCV002251919 | uncertain significance | not provided | 2021-08-31 | criteria provided, single submitter | clinical testing | |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV003155388 | SCV003844876 | likely pathogenic | 3-M syndrome | 2023-02-16 | criteria provided, single submitter | clinical testing | Variant summary: CUL7 c.4763T>C (p.Leu1588Pro) results in a non-conservative amino acid change located in the Cullin protein, neddylation domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 250766 control chromosomes. c.4763T>C has been reported in the literature in individuals affected with Three M Syndrome in the compound heterozygous and homozygous states (Hanson_2012, Hu_2017, Fan_2021). These data indicate that the variant may be associated with disease. Experimental evidence found that the L1588P mutation in CUL7 disrupted its interaction with endogenous CCDC8, its association with the membrane, and the ability to degrade LL5 protein (Wang_2019). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as likely pathogenic, and one laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. |
| Beijing Key Laboratory for Genetic Research of Skeletal Deformity, |
RCV001293688 | SCV001482316 | likely pathogenic | 3M syndrome 1 | 2019-05-31 | no assertion criteria provided | research |